Overview

Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Single Dose Lacosamide in Subjects With Renal Impairment Compared to Healthy Subjects

Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
To investigate the Pharmacokinetics (PK) of oral administered Lacosamide in renal impaired subjects and healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
UCB BIOSCIENCES GmbH
Treatments:
Lacosamide